Diadema Partners LP Lava Therapeutics Nv Call Options Transaction History
Diadema Partners LP
- $233 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LVTX
# of Institutions
23Shares Held
3.36MCall Options Held
100Put Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$2.01 Million0.16% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$748,7170.33% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3126KShares$122,5380.03% of portfolio
-
Pathway Financial Advisors LLC103KShares$99,4250.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$63,0500.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $25M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...